Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cochlear ( (AU:COH) ) has provided an announcement.
Cochlear Limited announced the cessation of certain securities, specifically 264 deferred performance rights and 513 service rights, due to unmet conditions as of June 30, 2025. This cessation reflects a lapse in conditional rights, which may impact the company’s capital structure and could have implications for stakeholders regarding the company’s performance metrics and strategic goals.
The most recent analyst rating on (AU:COH) stock is a Sell with a A$272.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants and related products, focusing on improving hearing for individuals with severe to profound hearing loss.
Average Trading Volume: 186,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.72B
For detailed information about COH stock, go to TipRanks’ Stock Analysis page.